ロード中...
Cross-talks among GBA mutations, glucocerebrosidase, and α-synuclein in GBA-associated Parkinson’s disease and their targeted therapeutic approaches: a comprehensive review
Current therapies for Parkinson’s disease (PD) are palliative, of which the levodopa/carbidopa therapy remains the primary choice but is unable to modulate the progression of neurodegeneration. Due to the complication of such a multifactorial disorder and significant limitations of the therapy, nume...
保存先:
| 出版年: | Transl Neurodegener |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7809876/ https://ncbi.nlm.nih.gov/pubmed/33446243 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40035-020-00226-x |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|